NEW YORK (Reuters) - Novo Nordisk A/S said on Thursday it believes its experimental type 2 diabetes treatment will be as effective as the Eli Lilly and Co drug expected to be its main rival and may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback